Prostate cancer stem cells: Clinical aspects and targeted therapies
Abstract: Despite decades of research and successful improvements in diagnosis and therapy, prostate cancer (PC) remains a major challenge. In recent years, it has become clear that PC stem cells (PCSCs) are the driving force in tumorigenesis, relapse, metastasis, and therapeutic resistance of PC. In this minireview, we discuss the impact of PCSCs in the clinical practice. Moreover, new therapeutic approaches to combat PCSCs are presented with the aim to achieve an improved outcome for patients with PC
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Frontiers in oncology. - 12 (2022) , 935715, ISSN: 2234-943X
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2022
- Creator
- DOI
-
10.3389/fonc.2022.935715
- URN
-
urn:nbn:de:bsz:25-freidok-2285769
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wolf, Isis
- Gratzke, Christian
- Wolf, Philipp
- Universität
Time of origin
- 2022
Other Objects (12)
Morphologie und Deformationsverhalten des Kniegelenkknorpels bei Kraftsportlern
Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
Incidental prostate cancer after holmium laser enucleation of the prostate - a narrative review
Apalutamid/ADT : erste Erfahrungen in der Therapie des mHSPC
Safety and efficacy of laser enucleation of the prostate in elderly patients – a narrative review
Extended safety and tolerability of darolutamide for nonmetastatic castration-resistant prostate cancer and adverse event time course in ARAMIS
A cross-sectional survey of physicians to understand biomarker testing and treatment patterns in patients with prostate cancer in the USA, EU5, Japan, and China
Thermal effects of thulium: YAG laser treatment of the prostate—an in vitro study
Thermal effects of thulium: YAG laser treatment of the prostate - an in vitro study
10 Jahre nach Erstzulassung : Erfahrungen mit Abirateronacetat in der Therapie des mCRPC
Reasons for new MIS. Let's be fair: iTIND, Urolift and Rezūm
Reasons for new MIS. Let's be fair: iTIND, Urolift and Rezūm
Morphologie und Deformationsverhalten des Kniegelenkknorpels bei Kraftsportlern
Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
Incidental prostate cancer after holmium laser enucleation of the prostate - a narrative review
Apalutamid/ADT : erste Erfahrungen in der Therapie des mHSPC
Safety and efficacy of laser enucleation of the prostate in elderly patients – a narrative review
Extended safety and tolerability of darolutamide for nonmetastatic castration-resistant prostate cancer and adverse event time course in ARAMIS
A cross-sectional survey of physicians to understand biomarker testing and treatment patterns in patients with prostate cancer in the USA, EU5, Japan, and China
Thermal effects of thulium: YAG laser treatment of the prostate—an in vitro study
Thermal effects of thulium: YAG laser treatment of the prostate - an in vitro study
10 Jahre nach Erstzulassung : Erfahrungen mit Abirateronacetat in der Therapie des mCRPC
Reasons for new MIS. Let's be fair: iTIND, Urolift and Rezūm
Reasons for new MIS. Let's be fair: iTIND, Urolift and Rezūm
Morphologie und Deformationsverhalten des Kniegelenkknorpels bei Kraftsportlern
Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer
Incidental prostate cancer after holmium laser enucleation of the prostate - a narrative review
Apalutamid/ADT : erste Erfahrungen in der Therapie des mHSPC
Safety and efficacy of laser enucleation of the prostate in elderly patients – a narrative review
Extended safety and tolerability of darolutamide for nonmetastatic castration-resistant prostate cancer and adverse event time course in ARAMIS
A cross-sectional survey of physicians to understand biomarker testing and treatment patterns in patients with prostate cancer in the USA, EU5, Japan, and China
Thermal effects of thulium: YAG laser treatment of the prostate—an in vitro study
Thermal effects of thulium: YAG laser treatment of the prostate - an in vitro study
10 Jahre nach Erstzulassung : Erfahrungen mit Abirateronacetat in der Therapie des mCRPC
Reasons for new MIS. Let's be fair: iTIND, Urolift and Rezūm